Preparation and evaluation of a suppository dosage form containing omeprazole

Chiyo Imamura, R. Nishi, M. Otagiri

Research output: Contribution to journalArticle

Abstract

A suppository containing omeprazole was prepared for use as a non-oral dosage form. The stability of omeprazole in different bases, Witepsol H15, Witepsol S55, Witepsol E75 and polyethylene glycol was investigated. Omeprazole was found to be stable only in Witepsol H15. The in-vitro release of omeprazole from Witepsol H15 was good and apparently obeyed a zero-order release pattern. The serum levels of omeprazole after administration of a single dose of the suppository were compared with the enteric formulation in four beagle dogs. The absorption rate from the suppository was significantly more rapid, compared with the commercially available enteric tablet, Omepral. The area under the serum omeprazole level-time curve, after administration of the suppository, was approximately equal to that of the enteric tablet. Similar results were obtained in four healthy volunteers. We conclude that omeprazole, in suppository form suppresses gastric juice secretion as effectively as the commercial enteric tablet. These results suggest that the suppository is an effective dosage form of omeprazole for patients who cannot tolerate oral administration in countries where injectable forms are not available.

Original languageEnglish
Pages (from-to)431-434
Number of pages4
JournalPharmaceutical Sciences
Volume3
Issue number9
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Suppositories
Omeprazole
Dosage Forms
Tablets
Gastric Juice
Serum
Oral Administration
Healthy Volunteers
Dogs
Injections
witepsol

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Preparation and evaluation of a suppository dosage form containing omeprazole. / Imamura, Chiyo; Nishi, R.; Otagiri, M.

In: Pharmaceutical Sciences, Vol. 3, No. 9, 1997, p. 431-434.

Research output: Contribution to journalArticle

Imamura, C, Nishi, R & Otagiri, M 1997, 'Preparation and evaluation of a suppository dosage form containing omeprazole', Pharmaceutical Sciences, vol. 3, no. 9, pp. 431-434.
Imamura, Chiyo ; Nishi, R. ; Otagiri, M. / Preparation and evaluation of a suppository dosage form containing omeprazole. In: Pharmaceutical Sciences. 1997 ; Vol. 3, No. 9. pp. 431-434.
@article{e6287ffcaf374c24a18bd8fdfd4399f5,
title = "Preparation and evaluation of a suppository dosage form containing omeprazole",
abstract = "A suppository containing omeprazole was prepared for use as a non-oral dosage form. The stability of omeprazole in different bases, Witepsol H15, Witepsol S55, Witepsol E75 and polyethylene glycol was investigated. Omeprazole was found to be stable only in Witepsol H15. The in-vitro release of omeprazole from Witepsol H15 was good and apparently obeyed a zero-order release pattern. The serum levels of omeprazole after administration of a single dose of the suppository were compared with the enteric formulation in four beagle dogs. The absorption rate from the suppository was significantly more rapid, compared with the commercially available enteric tablet, Omepral. The area under the serum omeprazole level-time curve, after administration of the suppository, was approximately equal to that of the enteric tablet. Similar results were obtained in four healthy volunteers. We conclude that omeprazole, in suppository form suppresses gastric juice secretion as effectively as the commercial enteric tablet. These results suggest that the suppository is an effective dosage form of omeprazole for patients who cannot tolerate oral administration in countries where injectable forms are not available.",
author = "Chiyo Imamura and R. Nishi and M. Otagiri",
year = "1997",
language = "English",
volume = "3",
pages = "431--434",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "9",

}

TY - JOUR

T1 - Preparation and evaluation of a suppository dosage form containing omeprazole

AU - Imamura, Chiyo

AU - Nishi, R.

AU - Otagiri, M.

PY - 1997

Y1 - 1997

N2 - A suppository containing omeprazole was prepared for use as a non-oral dosage form. The stability of omeprazole in different bases, Witepsol H15, Witepsol S55, Witepsol E75 and polyethylene glycol was investigated. Omeprazole was found to be stable only in Witepsol H15. The in-vitro release of omeprazole from Witepsol H15 was good and apparently obeyed a zero-order release pattern. The serum levels of omeprazole after administration of a single dose of the suppository were compared with the enteric formulation in four beagle dogs. The absorption rate from the suppository was significantly more rapid, compared with the commercially available enteric tablet, Omepral. The area under the serum omeprazole level-time curve, after administration of the suppository, was approximately equal to that of the enteric tablet. Similar results were obtained in four healthy volunteers. We conclude that omeprazole, in suppository form suppresses gastric juice secretion as effectively as the commercial enteric tablet. These results suggest that the suppository is an effective dosage form of omeprazole for patients who cannot tolerate oral administration in countries where injectable forms are not available.

AB - A suppository containing omeprazole was prepared for use as a non-oral dosage form. The stability of omeprazole in different bases, Witepsol H15, Witepsol S55, Witepsol E75 and polyethylene glycol was investigated. Omeprazole was found to be stable only in Witepsol H15. The in-vitro release of omeprazole from Witepsol H15 was good and apparently obeyed a zero-order release pattern. The serum levels of omeprazole after administration of a single dose of the suppository were compared with the enteric formulation in four beagle dogs. The absorption rate from the suppository was significantly more rapid, compared with the commercially available enteric tablet, Omepral. The area under the serum omeprazole level-time curve, after administration of the suppository, was approximately equal to that of the enteric tablet. Similar results were obtained in four healthy volunteers. We conclude that omeprazole, in suppository form suppresses gastric juice secretion as effectively as the commercial enteric tablet. These results suggest that the suppository is an effective dosage form of omeprazole for patients who cannot tolerate oral administration in countries where injectable forms are not available.

UR - http://www.scopus.com/inward/record.url?scp=0031426619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031426619&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 431

EP - 434

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 9

ER -